Literature DB >> 12189240

Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.

Sophie Lanone1, Tao Zheng, Zhou Zhu, Wei Liu, Chun Geun Lee, Bing Ma, Qingsheng Chen, Robert J Homer, Jingming Wang, Lesley A Rabach, Morgan E Rabach, J Michael Shipley, Steven D Shapiro, Robert M Senior, Jack A Elias.   

Abstract

IL-13 potently stimulates eosinophilic and lymphocytic inflammation and alveolar remodeling in the lung, effects that depend on the induction of various matrix metalloproteinases (MMPs). Here, we compared the remodeling and inflammatory effects of an IL-13 transgene in lungs of wild-type, MMP-9-deficient, or MMP-12-deficient mice. IL-13-induced alveolar enlargement, lung enlargement, compliance alterations, and respiratory failure and death were markedly decreased in the absence of MMP-9 or MMP-12. Moreover, IL-13 potently induced MMPs-2, -12, -13, and -14 in the absence of MMP-9, while induction of MMPs-2, -9, -13, and -14 by IL-13 was diminished in the absence of MMP-12. A deficiency in MMP-9 did not alter eosinophil, macrophage, or lymphocyte recovery, but increased the recovery of total leukocytes and neutrophils in bronchoalveolar lavage (BAL) fluids from IL-13 transgenic mice. In contrast, a deficiency in MMP-12 decreased the recovery of leukocytes, eosinophils, and macrophages, but not lymphocytes or neutrophils. These studies demonstrate that IL-13 acts via MMPs-9 and -12 to induce alveolar remodeling, respiratory failure, and death and that IL-13 induction of MMPs-2, -9, -13, and -14 is mediated at least partially by an MMP-12-dependent pathway. The also demonstrate that MMPs-9 and -12 play different roles in the generation of IL-13-induced inflammation, with MMP-9 inhibiting neutrophil accumulation and MMP-12 contributing to the accumulation of eosinophils and macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189240      PMCID: PMC150413          DOI: 10.1172/JCI14136

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  57 in total

1.  Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.

Authors:  M Corbel; S Caulet-Maugendre; N Germain; S Molet; V Lagente; E Boichot
Journal:  J Pathol       Date:  2001-04       Impact factor: 7.996

2.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.

Authors:  G A Finlay; K J Russell; K J McMahon; E M D'arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

3.  Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis.

Authors:  K Ohshima; M Akaiwa; R Umeshita; J Suzumiya; K Izuhara; M Kikuchi
Journal:  Histopathology       Date:  2001-04       Impact factor: 5.087

4.  The role of metalloelastase in immune complex-induced acute lung injury.

Authors:  R L Warner; C S Lewis; L Beltran; E M Younkin; J Varani; K J Johnson
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

Authors:  Z Liu; X Zhou; S D Shapiro; J M Shipley; S S Twining; L A Diaz; R M Senior; Z Werb
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

6.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema.

Authors:  T Zheng; Z Zhu; Z Wang; R J Homer; B Ma; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

7.  Unsuspected pseudophysiologic emphysema in chronic persistent asthma.

Authors:  A F Gelb; N Zamel
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

8.  Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.

Authors:  M Suga; K Iyonaga; T Okamoto; Y Gushima; H Miyakawa; T Akaike; M Ando
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

9.  Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation.

Authors:  I Ohno; H Ohtani; Y Nitta; J Suzuki; H Hoshi; M Honma; S Isoyama; Y Tanno; G Tamura; K Yamauchi; H Nagura; K Shirato
Journal:  Am J Respir Cell Mol Biol       Date:  1997-03       Impact factor: 6.914

10.  Interferon gamma induction of pulmonary emphysema in the adult murine lung.

Authors:  Z Wang; T Zheng; Z Zhu; R J Homer; R J Riese; H A Chapman; S D Shapiro; J A Elias
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  104 in total

Review 1.  New insights into the pathogenesis of asthma.

Authors:  Jack A Elias; Chun Geun Lee; Tao Zheng; Bing Ma; Robert J Homer; Zhou Zhu
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

2.  Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.

Authors:  Koichi Shimizu; Masayoshi Shichiri; Peter Libby; Richard T Lee; Richard N Mitchell
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 3.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

5.  Genome-Wide Methylation Study Identifies an IL-13-induced Epigenetic Signature in Asthmatic Airways.

Authors:  Jessie Nicodemus-Johnson; Katherine A Naughton; Jyotsna Sudi; Kyle Hogarth; Edward T Naurekas; Dan L Nicolae; Anne I Sperling; Julian Solway; Steven R White; Carole Ober
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 6.  Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction.

Authors:  Alan J Mouton; Osvaldo J Rivera Gonzalez; Amanda R Kaminski; Edwin T Moore; Merry L Lindsey
Journal:  Pharmacol Res       Date:  2018-10-28       Impact factor: 7.658

Review 7.  Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease.

Authors:  Michael J Holtzman; Jeffrey W Tyner; Edy Y Kim; Mindy S Lo; Anand C Patel; Laurie P Shornick; Eugene Agapov; Yong Zhang
Journal:  Proc Am Thorac Soc       Date:  2005

8.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.

Authors:  Andreas A Erdmann; Zhan-Guo Gao; Unsu Jung; Jason Foley; Todd Borenstein; Kenneth A Jacobson; Daniel H Fowler
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice.

Authors:  Nobuaki Mizutani; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 10.  What drives the peripheral lung-remodeling process in chronic obstructive pulmonary disease?

Authors:  James C Hogg; John E McDonough; John V Gosselink; Shizu Hayashi
Journal:  Proc Am Thorac Soc       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.